Related Experiment Video

Updated: May 27, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Role of microRNAs in diabetes and its cardiovascular complications

Saran Shantikumar1, Andrea Caporali, Costanza Emanueli

  • 1Laboratory of Vascular Pathology and Regeneration, Bristol Heart Institute and School of Clinical Science-Regenerative Medicine Section, University of Bristol, Bristol Royal Infirmary, Marlborough Street, BS2 8HW Bristol, UK.

Cardiovascular Research
|November 9, 2011
PubMed

Insights

MicroRNAs (miRNAs) are crucial in diabetes and its cardiovascular issues. This review explores their role in disease development, as biomarkers, and potential therapeutic targets for diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Diabetes mellitus is a prevalent metabolic disorder with significant health implications.
  • MicroRNAs (miRNAs), small non-coding RNAs, regulate numerous physiological processes, including glucose metabolism.
  • Emerging evidence links aberrant miRNA expression to diabetes pathogenesis and complications.

Purpose of the Study:

  • To review the dysregulation of miRNAs in diabetes.
  • To examine the role of miRNAs in endothelial dysfunction, cardiovascular disease, and diabetic retinopathy.
  • To discuss the potential of miRNAs as diagnostic biomarkers and therapeutic targets for diabetes.

Main Methods:

  • Literature review of studies investigating miRNA involvement in diabetes.
  • Analysis of research on miRNA expression patterns in diabetic conditions.
  • Synthesis of findings on miRNA functions in diabetes-related complications.

Main Results:

  • Aberrant expression of specific miRNAs is observed in diabetes.
  • miRNAs contribute to the pathogenesis of endothelial dysfunction, cardiovascular disease, and diabetic retinopathy.
  • miRNAs show promise as circulating biomarkers for diabetes and its complications.

Conclusions:

  • MicroRNA dysregulation is integral to diabetes pathogenesis and associated cardiovascular complications.
  • Targeting miRNAs offers a potential therapeutic strategy for managing diabetes.
  • miRNAs represent a promising avenue for novel diagnostic and therapeutic approaches in diabetes care.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...